サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1529871

DNAおよび遺伝子クローニングサービスの市場規模、シェア、動向分析レポート：サービス別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
DNAおよび遺伝子クローニングサービスの市場規模、シェア、動向分析レポート：サービス別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年07月26日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

DNAおよび遺伝子クローニングサービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のDNAおよび遺伝子クローニングサービス市場規模は、2024年から2030年にかけて15.43%のCAGRで成長し、2030年には68億2,000万米ドルに達すると予測されています。

遺伝子治療の受け入れ拡大やDNA・遺伝子クローニング技術の進歩は、市場成長を促進する要因として期待されています。さらに、個別化医療に対する需要の高まりが市場成長をさらに促進します。

遺伝子クローニングは、疾患の原因となる特定の遺伝子変異を特定することで、個別化治療の開発を促進します。遺伝子治療によってこれらの変異を標的とすることで、個別化医療はより効果的で的を絞った治療の選択肢を提供します。遺伝子クローニング技術を個別化医療に組み込むことで、DNAおよび遺伝子クローニングサービス市場のさらなる成長が期待されます。治療や診断のための新たな遺伝子標的が発見され続けるにつれて、個別化治療アプローチをサポートする高度なDNAクローニングサービスに対する需要は増加すると思われます。

COVID-19パンデミックはDNAおよび遺伝子クローニングサービス市場に大きな影響を与えました。COVID-19ワクチンと治療に対する緊急の必要性に後押しされた合成生物学製品に対する需要の増加は、クローニング技術の研究開発（R&D）を加速させました。さらに、パンデミックによってもたらされた課題にもかかわらず、DNAおよび遺伝子クローニング・サービス市場は、新規技術の採用の増加、遺伝子治療に対する需要の高まり、遺伝子工学の継続的な進歩により、安定した成長を続けると予想されます。

しかし、遺伝子クローニング・合成技術の悪用が懸念されるのは、生物兵器を開発するための合成生物学技術によって有害な病原体を作り出すことです。合成DNAの不適切な取り扱いや廃棄は、環境汚染につながる可能性があります。環境に放出された人工生物は生態系に影響を及ぼす可能性があります。

DNAおよび遺伝子クローニングサービス市場レポート・ハイライト

  • 遺伝子合成は、鋳型を必要とせずにカスタムDNA配列の作成を可能にすることで、合成生物学において重要な役割を果たすため、2023年にはサービス分野で優位を占めました。
  • 2023年には、DNAシーケンシングが収益面でアプリケーションセグメントを支配し、2024年から2030年にかけて最も高いCAGRで成長すると予測されます。さらに、突然変異誘発セグメントは、予測期間中にCAGRで大きく成長すると見られています。
  • 学術・研究機関は、2023年に38.41%の最大シェアを占め、最終用途市場を独占しました。これは、新規の遺伝子治療法や遺伝子操作されたバイオテクノロジー製品を市場に投入するための調査への多大な貢献によるものです。
  • CMOとCROのセグメントは、高度な研究と製造技術への投資の増加により、2024年から2030年にかけて最も速いCAGRで成長すると予測されています。
  • 北米地域は、研究開発活動への投資の増加、個別化医療への需要の高まり、高度なバイオテクノロジー研究インフラなどの要因により、2023年に40.98％のシェアを獲得し、DNAおよび遺伝子クローニングサービス市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 DNAおよび遺伝子クローニングサービス市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
  • DNAおよび遺伝子クローニングサービス市場分析ツール

第4章 DNAおよび遺伝子クローニングサービス市場：サービス別推定・動向分析

  • セグメントダッシュボード
  • 世界のDNAおよび遺伝子クローニングサービス市場のサービス別変動分析
  • 世界のDNAおよび遺伝子クローニングサービス市場規模と動向分析（サービス別、2018年～2030年）
  • 遺伝子合成
  • カスタムクローン
  • サブクローニング
  • その他

第5章 DNAおよび遺伝子クローニングサービス市場：用途別推定・動向分析

  • セグメントダッシュボード
  • 世界のDNAおよび遺伝子クローニングサービス市場の用途別変動分析
  • 世界のDNAおよび遺伝子クローニングサービス市場規模と動向分析（用途別、2018年～2030年）
  • DNA配列解析
  • 突然変異誘発
  • ジェノタイピング
  • その他

第6章 DNAおよび遺伝子クローニングサービス市場：最終用途別推定・動向分析

  • セグメントダッシュボード
  • 世界のDNAおよび遺伝子クローニングサービス市場の最終用途別変動分析
  • 世界のDNAおよび遺伝子クローニングサービス市場規模と動向分析、最終用途別、2018年から2030年
  • 学術調査機関
  • 製薬・バイオテクノロジー企業
  • CMOとCRO

第7章 DNAおよび遺伝子クローニングサービス市場：地域別推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2023年
  • 企業プロファイル/リスト
    • Bio-Techne
    • Charles River Laboratories
    • Eurofins Scientific
    • GenScript
    • Danaher Corporation
    • Syngene International Limited
    • Twist Bioscience
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Curia Global, Inc.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global DNA and gene cloning services market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 4 Global DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America DNA and gene cloning services market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 8 North America DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 11 U.S. DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 14 Canada DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 17 Mexico DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe DNA and gene cloning services market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 21 Europe DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 24 Germany DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 27 UK DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 30 France DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 31 France DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 33 Italy DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 36 Spain DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 39 Denmark DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 42 Sweden DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 45 Norway DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific DNA and gene cloning services market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 52 China DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 53 China DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 55 Japan DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 58 India DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 59 India DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 61 South Korea DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 64 Australia DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 67 Thailand DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America DNA and gene cloning services market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 71 Latin America DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 74 Brazil DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 77 Argentina DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA DNA and gene cloning services market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 81 MEA DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 84 South Africa DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 90 UAE DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait DNA and gene cloning services market, by service, 2018 - 2030 (USD Million)
  • Table 93 Kuwait DNA and gene cloning services market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait DNA and gene cloning services market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 DNA and gene cloning services market: Market outlook
  • Fig. 5 DNA and gene cloning services market: Segment outlook
  • Fig. 6 DNA and gene cloning services market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 DNA and gene cloning services market driver impact
  • Fig. 9 DNA and gene cloning services market restraint impact
  • Fig. 10 DNA and gene cloning services market: Service outlook and key takeaways
  • Fig. 11 DNA and gene cloning services market: Service movement analysis
  • Fig. 12 Gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Custom cloning market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Sub-cloning market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 DNA and gene cloning services market: Application outlook and key takeaways
  • Fig. 17 DNA and gene cloning services market: Application movement analysis
  • Fig. 18 DNA sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Mutagenesis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Genotyping market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 DNA and gene cloning services market: End use outlook and key takeaways
  • Fig. 23 DNA and gene cloning services market: End use movement analysis
  • Fig. 24 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 26 CMOs & CROs market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 27 Global DNA and gene cloning services market: Regional outlook and key takeaways
  • Fig. 28 Global DNA and gene cloning services market: Regional movement analysis
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-383-8

DNA and Gene Cloning Services Market Growth & Trends:

The global DNA and gene cloning services market size is anticipated to reach USD 6.82 billion by 2030, growing at a CAGR of 15.43% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising acceptance of gene therapy and advancements in DNA and gene cloning technology are factors expected to propel market growth. Moreover, the increasing demand for personalized medicine further drives market growth.

Gene cloning facilitates the development of personalized treatments by identifying specific genetic mutations responsible for diseases. By targeting these mutations through gene therapy, personalized medicine offers more effective and targeted treatment options. Integrating gene cloning technologies into personalized medicine is expected to drive further growth in the DNA and gene cloning services market. As research continues to uncover new genetic targets for therapy and diagnostics, the demand for advanced DNA cloning services will likely increase to support personalized treatment approaches.

The COVID-19 pandemic has significantly impacted the DNA and gene cloning services market. The increased demand for synthetic biology products, driven by the urgent need for COVID-19 vaccines and treatments, has accelerated research and development (R&D) in cloning technology. Moreover, despite the challenges posed by the pandemic, the DNA and gene cloning services market is expected to continue growing steadily due to the increasing adoption of novel technologies, the rising demand for gene therapies, and ongoing advancements in genetic engineering.

However, one of the primary concerns of the misuse of gene cloning and synthesis technology is the creation of harmful pathogens through synthetic biology techniques to develop bioweapons. Improper handling or disposal of synthetic DNA could lead to environmental contamination. Engineered organisms released into the environment could have ecological consequences.

DNA and Gene Cloning Services Market Report Highlights:

  • Gene synthesis dominated the service segment in 2023 as they play a crucial role in synthetic biology by enabling the creation of custom DNA sequences without the need for a template.
  • In 2023, DNA sequencing dominated the application segment in terms of revenue and is expected to grow at the highest CAGR from 2024 to 2030. Furthermore, mutagenesis segment is expected to grow at a significant CAGR over the forecast period.
  • Academic & research institutes dominated the end use market with the largest share of 38.41% in 2023, driven by their significant contribution in the R&D to bring novel gene therapy treatments and engineered biotechnological products to market.
  • The CMOs & CROs segment is anticipated to grow at the fastest CAGR from 2024 to 2030 due to their increasing adoption and investment in advanced research and manufacturing technologies.
  • North America region dominated the DNA and gene cloning services market with a share of 40.98% in 2023 owing to factors such as increasing investments in R&D activities, rising demand for personalized medicine, and advanced biotechnology research infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. DNA and Gene Cloning Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in gene and DNA cloning technology
      • 3.2.1.2. Rising acceptance of gene therapies
      • 3.2.1.3. Increasing demand for personalized medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Ethical challenges with the use of gene cloning and synthesis technology
  • 3.3. DNA and Gene Cloning Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. DNA and Gene Cloning Services Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global DNA and Gene Cloning Services Market Service Movement Analysis
  • 4.3. Global DNA and Gene Cloning Services Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Gene Synthesis
    • 4.4.1. Gene synthesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Custom Cloning
    • 4.5.1. Custom cloning market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Sub-cloning
    • 4.6.1. Sub-cloning market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. DNA and Gene Cloning Services Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global DNA and Gene Cloning Services Market Application Movement Analysis
  • 5.3. Global DNA and Gene Cloning Services Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. DNA Sequencing
    • 5.4.1. DNA sequencing market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Mutagenesis
    • 5.5.1. Mutagenesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Genotyping
    • 5.6.1. Genotyping market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. DNA and Gene Cloning Services Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global DNA and Gene Cloning Services Market End Use Movement Analysis
  • 6.3. Global DNA and Gene Cloning Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Academic & Research Institutes
    • 6.4.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. CMOs & CROs
    • 6.6.1. CMOs & CROs market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. DNA and Gene Cloning Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.4.1.3. Competitive scenario
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Canada market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.4.2.3. Competitive scenario
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.4.3.3. Competitive scenario
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.5.1.3. Competitive scenario
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.5.2.3. Competitive scenario
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. France market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.5.3.3. Competitive scenario
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.5.4.3. Competitive scenario
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.5.5.3. Competitive scenario
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Norway market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.5.6.3. Competitive scenario
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.5.7.3. Competitive scenario
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.5.8.3. Competitive scenario
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Japan market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.6.1.3. Competitive scenario
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. India market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.6.3.3. Competitive scenario
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Australia market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.6.4.3. Competitive scenario
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.6.5.3. Competitive scenario
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.6.6.3. Competitive scenario
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.7.1.3. Competitive scenario
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.7.2.3. Competitive scenario
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.8.1.3. Competitive scenario
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.8.2.3. Competitive scenario
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. UAE market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.8.3.3. Competitive scenario
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
      • 7.8.4.3. Competitive scenario

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Bio-Techne
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Charles River Laboratories
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Eurofins Scientific
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Danaher Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Syngene International Limited
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Twist Bioscience
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Thermo Fisher Scientific, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Merck KGaA
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Service benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Curia Global, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Service benchmarking
      • 8.4.10.4. Strategic initiatives